ARTIGOS
Introduction
Currently, there is a growing concern by health institutions, private or public, regarding better results in health assistance, which reflects a competitive system, where the increase in the volume of patients, reduction in the length of hospital stay (LOS), reduction in health care costs, and good results are regarded as guarantees of survival in the health market. 1 LOS is one of the institutional quality indicators used to define the yield and productivity per hospital bed in each specialty. It is important to note its relevance to health care managers, as this indicator makes it possible to evaluate the efficiency of a certain facility, as well as its use as a basis for measuring the number of hospital beds required to provide assistance to the population in a specific area. 2, 3 For patients submitted to coronary artery bypass grafting (CABG), LOS has substantially decreased in the last two decades. 4 In Brazil, LOS is measured through the average length of stay (ALOS), which refers to the LOS and reflects factors that may increase the stay such as complexity, chronicity, and psychiatric treatments. 2 Studies have shown that possible differences in severity, intensity, and number of comorbidities, in addition to social factors, may be determinant for an increase in the LOS in patients of the Brazilian Unified Health System (Sistema Único de Saúde -SUS). [5] [6] [7] Conversely, factors such as LOS and cost restrictions by health plans and private patients and a differentiated attention by healthcare professionals may reduce the LOS in patients included in such categories. [8] [9] [10] Therefore, it is important to evaluate whether there is a difference in the LOS of SUS patients compared to health plans and private patients.
Thus, this study aimed to verify possible differences in the LOS of patients submitted to CABG, according to the hospital payer, whether SUS, health plans, or private.
Methods
This study is based on an electronic database, composed of 3,010 patients submitted to CABG at the Hospital Beneficência Portuguesa de São Paulo, who are 18 years old or older. The study was conducted from July 8, 2009 to July 26, 2010, including data from 70.0% of all CABGs performed at the hospital during this period.
For this study, a retrospective survey was conducted in this database. Patients were divided into two groups according to the payer. The SUS group was composed of patients from the SUS, in which the payer is the Brazilian government, and the non-SUS group encompassed patients whose treatment was paid by health plans, insurance companies, or private (in which the bill is the responsibility of the patient). 170 patients were excluded from the total database: 160 patients who died, seven patients who were not discharged from hospital until the end of this study (one-year follow-up), and three patients whose treatment was paid by the Associação Portuguesa de Beneficiência (it was not possible to classify them as SUS or non-SUS). Therefore, the total sample comprised 2,840 patients. LOSs were assessed in terms of days: (1) total length of stay (TLOS), which is the period from admission until hospital discharge; (2) waiting time for surgery (WTS), which is the period from admission until the moment in which the patient is directed to the operating room to undergo CABG; (3) intensive care unit length of stay (ICULOS), which is the period in which the patient remains in the intensive care unit (ICU) after CABG (new admissions to the ICU were not taken into account); and (4) postoperative length of stay (PLOS), which is the period between the discharge from ICU and hospital discharge.
The following database variables were selected for this study: age, gender, hospital payer (SUS, health plans, or private), WTS, ICULOS, PLOS and TLOS (in days), EuroScore, surgery status (elective, urgent/emergency), cardiopulmonary bypass (CPB) support, procedures associated with the CABG (valve, cardiac, non-cardiac), ICU readmission, and existence of any postoperative complication.
Statistical analysis
Initially, all variables were descriptively analyzed. For quantitative variables, this analysis was performed by observing minimum and maximum values, and the calculation of averages, standard deviations, and medians. For qualitative variables, the absolute and relative frequencies were calcu lated.
Student's t-test was used to compare averages from both groups. 11 The Mann-Whitney nonparametric test was used 11 when the assumption of normality of data was rejected. The chi-squared test or Fisher's exact test were used to test the homogeneity among the proportions. 11 The significance level used for the tests was set at 5%.
Results
The 2,840 patients evaluated were between 30 and 89 years old (average of 61.9 years), and 70.2% were male. Regarding the payer, 92.1% belonged to the SUS group and 7.9% to the non-SUS group. The SUS and non-SUS groups did not show significant differences as to the WTS (2.59 ± 3.10 vs. 3,02 ± 3.70 days for SUS and non-SUS respectively; p = 0.790). However, the groups differed regarding ICULOS (2.17 ± 3.84 vs. 2.52 ± 2.72 days for SUS and non-SUS respectively; p < 0.001), PLOS (8.34 + 10.32 vs. 9.19 ± 6.97 days for SUS and non-SUS respectively; p < 0.001) and regarding the TLOS (10.93 ± 11.08 vs. 12.21 ± 8.20 days for SUS and non-SUS respectively ; p < 0.001) , as shown in Table  1 . The TLOS in the non-SUS group is higher by more than one day in comparison with SUS patients. More occurrences of more-than-seven-day TLOS were also verified in the non-SUS group than in the SUS group (78.0% for non-SUS vs. 61.4% for SUS, p < 0.001).
Regarding preoperative characteristics, it was observed that the average age was not significantly different between the groups (61.8 ± 9.33 vs. 62.94 ± 10.39 for SUS and non-SUS respectively; p = 0.119). The number of women was greater in the SUS group than in the non-SUS group (30.6% vs. 20.6% [p = 0.002]).
The expected mortality, calculated by the average logistic EuroScore, ranged in the total sample from 0.88% to 34.75%, with an average of 2.88%, and it did not differ between the groups (2.81 ± 2.71 vs. 3.58 ± 4.02 for SUS and non-SUS respectively; p = 0.566). The EuroScore is a model of risk stratification in CABG initially validated in 128 centers of European countries, and subsequently in non-European populations. Table 2 .
Discussion
The results of this study showed that the total LOS, ICULOS, and PLOS of patients submitted to CABG at the Hospital Beneficência Portuguesa in São Paulo were different between SUS and non-SUS groups. Only with respect to WTS was there no difference between the groups.
A study conducted in the city of Belo Horizonte, Brazil, showed similar TLOS, ICULOS, and PLOS in the SUS and the non-SUS groups, and a greater WTS in the SUS group. 5 The average WTS in this study was 2.6 days, and meets the current institutional efforts in reducing the preoperative hospital stay. Some authors, by analyzing WTS costs of elective surgeries in public hospitals, verified that the efficiency in the management of health services could reduce this time, with consequent reduction in costs and increase in availability of hospital beds/day. 13 The non-SUS group presented a longer ICULOS (2.5 days for non-SUS vs. 2.2 days for SUS; p < 0.001), which was below the average reported by a national study conducted in the 1990s (3.8 days). 14 In the United States, the average ICULOS after a CABG is 2 days. 15 A study conducted in Brazil focusing on minimally invasive CABG showed an average ICULOS of 18 hours. 16 There was a significant difference in the average PLOS between the groups (8.3 days in the SUS group vs. 9.2 days in the non-SUS group [p < 0.001]). A study based on the US Society of Thoracic Surgeons' National Database with 496,797 isolated CABGs performed from January 1997 to January 2001 in 587 hospitals, considers as ideal a PLOS of less than five days. 15 An early discharge (on day four of the postoperative period) protocol was used in a study with patients submitted to isolated CABG, aiming at evaluating the safety of the hospital discharge and reduced PLOS. Patients were divided into a group of regular discharge (control) and another group of early discharge. Before the study, PLOS was between 7.8 days. For patients in which the early discharge protocol was applied, the average PLOS was 4.7 days, while in the control group, it was 7.7 days (p < 0.0001). The reduction in PLOS resulted in a significant reduction in costs; there was no increase in mortality within 30 days of postoperative period, and the incidence of nonfatal perioperative complications was similar in both groups. Regarding readmissions, the rate was 8.4% in the control group versus 3.8% in the early discharge group. The study concluded that the reduction in the elective PLOS to 4 days is safe and may be a way to reduce health care costs. 17 The average LOS of all patients in this study (SUS and non-SUS) was 11 days (± 10.89), which shows a progressive decrease in comparison with previous studies. Data from 41,989 patients submitted to the CABG in the SUS between 1996 and 1998 at 131 hospitals located in 22 Brazilian states showed an average LOS of 14.5 days. 14 Another study, conducted between 2005 and 2007 with 63,529 SUS patients in 191 hospitals, showed an average LOS of 12 days, with no difference between low-surgical-volume (12.08 ± 5.52) and high-surgical-volume (12.5 ± 7.70) hospitals. 18 Studies that evaluated only revascularizations without cardiopulmonary bypass indicated a maximum LOS of five days 16 or average LOS of seven days. 19 In a study assessing the LOS of 66,587 patients submitted to CABG from 2007 to 2009 in ten European countries, the average LOS ranged from nine to 17 days. 20 In the present study, TLOS longer than seven days occurred more frequently in the non-SUS group (78.0% for non-SUS vs. 61.4% for SUS [p < 0.001]), as shown in Table 3 . Some authors regard as lengthy a TLOS higher than 12 days, 21 while others considerer that only TLOSs longer than 14 days 15 are lengthy.
With respect to preoperative, intraoperative, and postoperative characteristics, differences between the SUS and non-SUS groups regarding gender, urgent and emergency surge ry, and surgery with CPB were observed. There was no significant difference between the SUS and non-SUS groups regarding age, EuroScore, ICU readmission, and evolution of any complication during the postoperative period.
The SUS group had significantly more women than the non-SUS group (p = 0.002), and also showed a reduced incidence of surgeries without CPB. Non-elective surgeries (urgent/ emergency) occurred more in the non-SUS group (seven patients [3.1%] vs. 17 patients [0.7%], p = 0.002).
Significant differences were observed in the studied LOS; patients of the non-SUS group have longer ICULOS, PLOS, and TLOS. New studies are required to identify the reason for the differences in the LOSs between the study groups, and to assess whether this occurs in other health institutions.
A hypothesis for the higher LOSs observed in the non-SUS group is that health care plans and private patients are more conscious about their conditions and rights, directly interfering in hospital discharge, an act that is shared or consented by doctors. Another hypothesis is that the major requirement by the non-SUS group is based on reasons that are not an obstacle for the physician to extend his/her patients stay, in addition to the inattention of the controlling institutions that allow longer stays and, finally, that patients from other states need to be discharged in excellent clinical conditions, provided that they require long-distance transportation.
Although the PLOS observed in the present study was consistent with those observed in ten European countries, 20 it was above that reported in the USA, where the average was 6.9 days. 15 It is important that other studies are performed in order to evaluate whether the discharge of SUS patients is premature or if the discharge of health plan patients is overdue.
Conclusion
Patients submitted to a CABG paid by health plans or with private resources presented longer TLOS, ICULOS, and PLOS than patients funded by the SUS. New studies are required to identify the reason for these differences and to assess whether this occurs in other health institutions.
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